Christopher Whitfield - Batswadi Pharmaceuticals

Christopher founded Batswadi Pharmaceuticals in October 2005 as a specialist healthcare company focusing on four core business areas: pharmaceuticals, diagnostics, research and development, and consumer health. After jump-starting the company by leading a management buy-out of Eli Lilly’s insulin portfolio in South Africa, Christopher has quickly built Batswadi into a diversified company with significant potential. As the only black-empowered (majority-owned by historically disadvantaged South Africans) pharmaceutical company in South Africa, Batswadi is a rising star in the pharmaceutical industry.

Christopher Whitfield - Batswadi Pharmaceuticals

Christopher founded Batswadi Pharmaceuticals in October 2005 as a specialist healthcare company focusing on four core business areas: pharmaceuticals, diagnostics, research and development, and consumer health. After jump-starting the company by leading a management buy-out of Eli Lilly’s insulin portfolio in South Africa, Christopher has quickly built Batswadi into a diversified company with significant potential. As the only black-empowered (majority-owned by historically disadvantaged South Africans) pharmaceutical company in South Africa, Batswadi is a rising star in the pharmaceutical industry.